NCT00662870: Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
- State
- Completed
- Phase
- Phase 3
- People
- 1,941 taking part
- Started
- May 2001
- Primary completion
- Jan 2004
- Arms
- DAPTACEL Lot 1, DAPTACEL Lot 2, DAPTACEL Lot 3
- Results
- None posted
- 21 Apr 2008: Trial registered